BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27635382)

  • 21. CT appearance of parapneumonic effusions in children: findings are not specific for empyema.
    Donnelly LF; Klosterman LA
    AJR Am J Roentgenol; 1997 Jul; 169(1):179-82. PubMed ID: 9207521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema.
    Bouros D; Schiza S; Panagou P; Drositis J; Siafakas N
    Thorax; 1994 Sep; 49(9):852-5. PubMed ID: 7940420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
    Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
    Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
    Porcel JM; Vives M; Esquerda A
    Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Significance of Pleural Lactate Measurement in Critically Ill Patients with Parapneumonic Pleural Effusion.
    Ergün B; Küçük M; Yakar MN; Öztürk MC; Bayrak V; Emecen AN; Hancı V; Cömert B; Gökmen AN; Ergan B
    Thorac Res Pract; 2023 Sep; 24(5):245-252. PubMed ID: 37581374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.
    Heffner JE; Brown LK; Barbieri C; DeLeo JM
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1700-8. PubMed ID: 7767510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients.
    Luh SP; Chou MC; Wang LS; Chen JY; Tsai TP
    Chest; 2005 Apr; 127(4):1427-32. PubMed ID: 15821225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loculated empyema in a neonate successfully treated with chest tube thoracostomy and antibiotics.
    Diez JRV; Perez MLM; Malayan GV; Cenabre MVL
    Respir Med Case Rep; 2020; 31():101274. PubMed ID: 33209575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
    Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
    [No Abstract]   [Full Text] [Related]  

  • 30. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleural fluid parameters identifying complicated parapneumonic effusions.
    Jiménez Castro D; Díaz Nuevo G; Sueiro A; Muriel A; Pérez-Rodríguez E; Light RW
    Respiration; 2005; 72(4):357-64. PubMed ID: 16088277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of parapneumonic effusions.
    Light RW; Rodriguez RM
    Clin Chest Med; 1998 Jun; 19(2):373-82. PubMed ID: 9646988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase.
    Moulton JS; Benkert RE; Weisiger KH; Chambers JA
    Chest; 1995 Nov; 108(5):1252-9. PubMed ID: 7587425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial pleural fluid analysis in a new experimental model of empyema.
    Sasse SA; Causing LA; Mulligan ME; Light RW
    Chest; 1996 Apr; 109(4):1043-8. PubMed ID: 8635329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the management of complicated pleural effusion: From intrapleural agents to surgery.
    Sorino C; Mondoni M; Lococo F; Marchetti G; Feller-Kopman D
    Respir Med; 2022 Jan; 191():106706. PubMed ID: 34896966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
    Maskell NA; Gleeson FV; Darby M; Davies RJ
    Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid therapy and outcome of parapneumonic pleural effusions (STOPPE): Study protocol for a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Fitzgerald DB; Waterer GW; Read CA; Fysh ET; Shrestha R; Stanley C; Muruganandan S; Lan NSH; Popowicz ND; Peddle-McIntyre CJ; Rahman NM; Gan SK; Murray K; Lee YCG
    Medicine (Baltimore); 2019 Oct; 98(43):e17397. PubMed ID: 31651842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolytic treatment of complicated pediatric thoracic empyemas with intrapleural streptokinase.
    Ekingen G; Güvenç BH; Sözübir S; Tuzlaci A; Senel U
    Eur J Cardiothorac Surg; 2004 Sep; 26(3):503-7. PubMed ID: 15302043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Value of Pleural Cytology in the Diagnosis of Complicated Parapneumonic Effusions and Empyema Thoracis.
    Ferguson J; Kazimir M; Gailey M; Moore F; Schott E
    Pulm Med; 2020; 2020():7175451. PubMed ID: 32518695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrapleural therapy in management of complicated parapneumonic effusions and empyema.
    Ahmed AH; Yacoub TE
    Clin Pharmacol; 2010; 2():213-21. PubMed ID: 22291507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.